Lpl Financial LLC Forte Biosciences, Inc. Transaction History

Lpl Financial LLC

$196 Billion
Q2 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 15, 2021	SELL	$2.96 - $36.67 $29,295 - $362,922	-9,897 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$25.01 - $40.24 $15,831 - $25,471	-633 Reduced 6.01%	9,897 $339,000
Q4 2020 Feb 12, 2021	BUY	$28.66 - $46.79 $3,840 - $6,269	134 Added 1.29%	10,530 $383,000
Q3 2020 Nov 09, 2020	SELL	$14.71 - $50.69 $6,972 - $24,027	-474 Reduced 4.36%	10,396 $504,000
Q2 2020 Aug 13, 2020	BUY	$13.9 - $24.6 $151,093 - $267,402	10,870 New	10,870 $158,000

Others Institutions Holding FBRX

# of Institutions

33

Shares Held

19M

Call Options Held

3.1K

Put Options Held

0

Tybourne Capital Management (Hk) LTD Hong Kong, K3

3.62M
Shares

$20.8 Million
0.49% of portfolio
Perceptive Advisors LLC New York, NY

3.27M
Shares

$18.7 Million
0.05% of portfolio
Bvf Inc San Francisco, CA

2.98M
Shares

$17.1 Million
0.05% of portfolio
Cable Car Capital LLC San Francisco, CA

2.03M
Shares

$11.7 Million
1.15% of portfolio
Fred Alger Management, LLC New York, NY

1.84M
Shares

$10.6 Million
0.0% of portfolio

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $117M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.